Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of the Combination of Gemcitabine and Metformin in Treating Patients With Pancreatic Cancer After Curative Resection

NCT02005419 is registered in ClinicalTrials.gov with Xian-Jun Yu as lead sponsor.

NCT NCT02005419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02005419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of the Combination of Gemcitabine and Metformin in Treating Patients With Pancreatic Cancer After Curative Resection
Lead sponsor
Xian-Jun Yu
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2017
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia pancreatic adenocarcinoma, stage ib pancreatic adenocarcinoma, stage iia pancreatic adenocarcinoma, stage iib pancreatic adenocarcinoma